Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0534 per EA under NDC 68462034690. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462034690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090385On Market Since
2/25/2011
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 82.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0534 per EA |
|---|---|
| All-time high | $0.3735 (Apr 16, 2014) |
| All-time low | $0.0534 (Jun 17, 2026) |
| 52-week high | $0.0617 |
| 52-week low | $0.0534 |
| Median price | $0.0867 |
| Average price | $0.1214 |
| Largest weekly change | +51.3% (Apr 18, 2018) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0534 per EA (NDC 68462034690), effective Jun 24, 2026.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 82.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.0534 (Jun 17, 2026) to a high of $0.3735 (Apr 16, 2014), with a median of $0.0867 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LEVOCETIRIZINE 5 MG TABLET, but none are currently priced below it.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 68462034690) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification